Thomas Gramatté
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Antibiotics Pharmacokinetics and Efficacy
-
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 2
- Drug Transport and Resistance Mechanisms 2
-
- Pharmacogenetics and Drug Metabolism 2
- Cholinesterase and Neurodegenerative Diseases 1
- Drug-Induced Hepatotoxicity and Protection 1
- Co-authors
- Reinhard Oertel (3 shared papers)Wilhelm Kirch (2 shared papers)B Terhaag (2 shared papers)Ulrike Ebert (1 shared paper)Matthias Großmann (1 shared paper)Ute Hofmann (1 shared paper)Klaus Richter (1 shared paper)Michel Eichelbaum (1 shared paper)
- Journals
- Clinical Pharmacology & Therapeutics (3 papers)Journal of Pharmaceutical Sciences (1 paper)The Journal of Clinical Pharmacology (1 paper)Drug Metabolism and Disposition (1 paper)European Urology Supplements (1 paper)
- Partner nations
- Germany
In The Last Decade
Thomas Gramatté
7 papers receiving 347 citations
Peers
Comparison fields: 5 of 66
- Pharmacology 116
- Oncology 173
- Pediatrics, Perinatology and Child Health 108
- Pharmaceutical Science 31
- Anesthesiology and Pain Medicine 15
Countries citing papers authored by Thomas Gramatté
This map shows the geographic impact of Thomas Gramatté's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Gramatté with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Gramatté more than expected).
Fields of papers citing papers by Thomas Gramatté
This network shows the impact of papers produced by Thomas Gramatté. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Gramatté. The network helps show where Thomas Gramatté may publish in the future.
Co-authors
The 17 scholars most cited alongside Thomas Gramatté, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 106 | |
| 2 | 1999 | 74 | |
| 3 | 2001 | 57 | |
| 4 | 1997 | 49 | |
| 5 | 2013 | 46 | |
| 6 | 2002 | 26 | |
| 7 | 2002 | 5 |
About Thomas Gramatté
Thomas Gramatté is a scholar working on Oncology, Pharmacology, Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience, having authored 7 papers that have together received 363 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Urinary Bladder and Prostate Research (1 paper), Memory and Neural Mechanisms (1 paper), Urinary Tract Infections Management (1 paper), Cholinesterase and Neurodegenerative Diseases (1 paper), Drug-Induced Hepatotoxicity and Protection (1 paper) and Neuroscience and Neuropharmacology Research (1 paper). The work is most often cited by research in Pharmacology (116 citations), Oncology (173 citations), Pediatrics, Perinatology and Child Health (108 citations), Pharmaceutical Science (31 citations) and Anesthesiology and Pain Medicine (15 citations). Thomas Gramatté has collaborated with scholars based in Germany. Frequent co-authors include Reinhard Oertel, Wilhelm Kirch, B Terhaag, Ulrike Ebert, Matthias Großmann, Ute Hofmann, Klaus Richter, Michel Eichelbaum, Gerd Mikus and Sandra Schläfke. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Journal of Pharmaceutical Sciences, The Journal of Clinical Pharmacology, Drug Metabolism and Disposition and European Urology Supplements.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.